Evidence-based data from our psilocybin study, which enrolled over 8,000 individuals across the world, found that participants primarily reported using psilocybin alone (>40%), with friends who were also using (>25%), or with a sober friend or trip sitter (>15%). These reports are consistent with a recent investigation of psilocybin experiences wherein only 25% of respondents reported a “guide” or “sitter” present (Carbonaro et al., 2016). Most participants took psilocybin at home (>60%) or outdoors (>15%), and the median time of dosing was 4pm. However, it’s important to note that individuals from our study were especially experienced with psychedelics. Especially for first-time users, a guide, facilitator, or “trip sitter” is highly recommended to provide support during the experience. In fact, psychedelic users place high value on “trip sitters” who had experienced psychedelic and other non-ordinary states of consciousness, who had knowledge of the health and medical industry, psychedelic literature and/or had previously cared for other psychedelic consumers (Engel et al., 2022).
Always seek the advice of your physician or other qualified health care provider before undertaking a new health care regime. Unlimited Sciences does not give or substitute for medical advice. The products and services discussed are not intended to diagnose, cure, prevent or treat any disease. Please click here to read our full disclaimer.